- Home
- Applications
- north america
- chemotherapy
Show results for
Refine by
Chemotherapy Product Applications In North America
10 applications found
Delmitide is a TNF-alpha production inhibitor potentially for the treatment of chemotherapy-induced diarrhea. https://www.creative-peptides.com/product/delmitide-item-10-101-147-34916.html ...
ByCreative Peptides based in New York, NEW YORK (USA)
A defective gastrointestinal (GI) barrier is associated with multiple conditions of high unmet need, including inflammatory bowel disease, chemotherapy-induced gut injury, food allergies, and celiac disease. We are advancing novel, oral, non-immunosuppressive therapeutics to improve GI barrier function. ...
ByKallyope Inc. based in New York City, NEW YORK (USA)
Randomized clinical trials (RCT’s) have been shown significant improvement in clinical outcome when hyperthermia was added to radiotherapy and/or chemotherapy. In 2004 experts in clinical hyperthermia held a consensus meeting (Kadota Fund International Forum 2004) about the evidence of the published clinical results of the RCT’s. ...
ByPyrexar based in Salt Lake City, UTAH (USA)
Standard treatment for advanced colorectal cancer generally involves surgical resection and chemotherapy. However, the recent emergence of targeted therapies, particularly those that inhibit EGFR, has provided treatment options that extend survival for a subset of patients. ...
ByBiocept based in San Diego, CALIFORNIA (USA)
To date, the classification of cancers has been based solely on the phenotypic and genotypic characteristics of tumor cells. A new paradigm, scientifically well established and recommended by WHO guidelines, relies on the introduction of the immune response as a new prognostic parameter to predict and refine the clinical outcomes of cancer patients. Maximize patient survival rates with an assessment of the tumor immune response. ...
ByVeracyte based in Marseille Cedex 9, FRANCE
Surgery isn’t an option for every patient diagnosed with pancreatic cancer. But with the IntraOp® Mobetron® and electron IORT, more patients than ever before are eligible. And we know that those who are treated surgically have a higher chance of ...
ByIntraOp Medical, Inc. based in Sunnyvale, CALIFORNIA (USA)
In many therapeutic areas, current treatments involve significant side effects. Combining drug compounds with affinity agents that target specific cell surface receptors can dramatically reduce off-target effects and improve treatment effectiveness. In several studies, aptamer-mediated drug delivery has reduced toxicity and improved drug performance. ...
ByBase Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA)
As a diagnostic imaging tool, Breast MRI is used for a wide range of indications in breast disease management ...
ByAurora Healthcare US Corp. based in Danvers, MASSACHUSETTS (USA)
Building on our expertise in cell sorting tools incorporating shadow imaging for detection and characterization of cells, we are developing medical diagnostic devices leveraging these technologies, along with microfluidic integrated biosensors, to capture and quantify cells from unprocessed whole blood or other body fluids. This healthcare platform technology addresses significant underserved clinical needs in the home and primary care settings for innovative, inexpensive, accurate and easy-to-use point-of-care ...
ByZyMōt Fertility, Inc. based in Gaithersburg, MARYLAND (USA)
Micron's ISO 13485 certified, FDA registered cGMP orthopedic implant manufacturing solutions include precision machining, finishing, porous coatings, passivation, and ...
ByMicron Solutions based in Fitchburg, MASSACHUSETTS (USA)